AI-generated summary
The authors describe four patients with recurrent herpes labialis treated with either high-intensity laser therapy or methylene blue photodynamic therapy, each followed by low-level laser therapy. All four reported pain relief and no signs of recurrence over six months of follow-up. The authors state these results suggest a possible benefit, but the report covers only four cases.
- Participants
- 4
- Who or what was studied
- Four patients diagnosed with recurrent herpes labialis
- Limits stated in the abstract
- The report describes only four clinical cases, with no control group and no statistical analysis.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Laser, Low-level laser therapy, High-intensity laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.